ERBB2 and breast cancer: Moreover, the IV protocol provided a prolonged accumulation of iopamidol up to 25 min postinjection, as measured with the CT technique, as previously observed upon IV administration of several iodinated contrast media in a subcutaneous HER2+ breast cancer murine model [29].